GLG Pharma logo — Why Show the GSK Compound? Because the cancer cells become r...

GLG Pharma

Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's Compounds Reverse Resistance

Founded 2009 United States Jupiter, United States 3 employees Venture round Biotechnology, Health Care +1

General Information

Company Name GLG Pharma
Founded Year 2009
Location United States Jupiter, United States
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with GLG Pharma. To contact GLG Pharma, visit glgpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About GLG Pharma

GLG Pharma, Inc. (GLG) is a Jupiter, Florida-based clinical-stage biotechnology company focused on developing next-generation therapies for hyper-proliferative diseases including cancer, polycystic kidney disease, psoriasis, Crohn’s disease, and inflammatory bowel disease. The company's precision medicines target the STAT3 cancer gateway and employ integrative genomics-powered cell culture platform, Gx-C3TM, for personalized therapy. GLG's unique approach involves capturing patient cells, culturing and expanding them ex-vivo in a biomimetic, three-dimensional microenvironment and systematically screening them against a proprietary library of new chemical and repurposed small molecule inhibitors. Promisingly, the company is currently involved in clinical trials for Chronic Lymphocytic Leukemia (CLL - GLG-801) and Triple Negative Breast Cancer (TNBC). Additionally, GLG-302 is part of a Cancer Prevention Program in collaboration with the National Cancer Institute. The company received a Venture Round investment on 16 October 2012 from the Florida Institute for Commercialization. For more information, visit www.glgpharma.com or contact Richard Gabriel, CEO GLG Pharma, Inc. - 781-883-6639, [email protected].

Taxonomy: Clinical-stage, Precision Medicine, Cancer Therapy, STAT3 Inhibitors, Personalized Medicine, Clinical Trials, Oncology, Pharmaceutical Development, Repurposed Drugs, Cancer Research, Genomics, Hyperproliferative Diseases, Drug Development, Innovative Therapies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Florida Institute for Commercialization
16 Oct 2012
Venture Round Undisclosed 1
Florida Institute for Commercialization
10 May 2012

GLG Pharma Alternatives & Competitors

GLG Pharma vs

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developin...

Post-IPO Equity
10 employees
Biotechnology, Health Care
GLG Pharma vs

Pioneering the Next Generation of Precision Oncology

Series C
16 employees
Biotechnology, Health Care
GLG Pharma vs

A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet me...

Series A
22 employees
Biotechnology, Health Care

FAQ About GLG Pharma

Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's Compounds Reverse Resistance
GLG Pharma was founded in 2009.
GLG Pharma is headquartered in Jupiter, United States.
GLG Pharma operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Clinical-stage, Precision Medicine, Cancer Therapy and STAT3 Inhibitors.
GLG Pharma has approximately 3 employees.
GLG Pharma has completed 2 funding rounds. The latest funding stage is Venture round.
Top alternatives and competitors to GLG Pharma include Cascadian Therapeutics, Inc., Scorpion Therapeutics, Phoenix Molecular Designs, Forma Therapeutics, Developing New Drugs for AML and PDAC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GLG Pharma and Cascadian Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GLG Pharma, https://bouncewatch.com/company/glg-pharma, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes